ACADEMIC INFORMATION AND ADMISSIONS
Credits - 70 / European ECTS credits
Pre-selection process: Open
Inscriptions: from October 2019 to August 2020
Master Program – October 2020 to June 2021.
Full Time - Monday to Thursday from 18:00h. to 21:00h.
Language - English
The objective of the program is to understand the relationship and different agreements negotiation processes between biotechnology-based companies and pharmaceutical companies in new compound acquisitions. The main skills and topics are related with international business development, portfolio increase, new valuation compounds, deal terms and conditions, milestones and royalties, and the negotiation process.
The students of our master programs will have the opportunity to work in teams of some of the most important global pharmaceutical companies as well as new biotechnology companies, developing innovative products inside the biomedical sector. Their demanded profiles allow the students to work in different roles and departments in biotech companies, consultancies, pharmaceutical companies, technology transfer offices from hospitals and research centers.
I. Global Ecosystem in Drug Discovery
II. Scientific and Regulatory Developemt
III. Profesional and Personal Leadership
IV. Portfolio Management
V. Global Marketing
VI. Master's Thesis - Licensing Agreement and Acquisition